序号 |
标题 |
次数 |
作者 |
发布时间 |
74566 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
111 |
WYQ |
2024-12-25 |
74567 |
Methyltetrazine-CH2NHCO-PEG11-CH2-C≡CH的结构式 |
87 |
zyl |
2024-12-25 |
74568 |
cas:126695-58-7,4-Azido-2,3,5,6-tetrafluorobenzoic Acid N-Succinimidyl ester |
92 |
h |
2024-12-25 |
74569 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
91 |
WYQ |
2024-12-25 |
74570 |
cas:850180-76-6,3-azidopropanoate-N-hydroxysuccinimide ester |
103 |
h |
2024-12-25 |
74571 |
Methyltetrazine-CH2NHCO-PEG6-CH2-C≡CH的介绍 |
123 |
zyl |
2024-12-25 |
74572 |
cas:906564-59-8,5-Hexynoic Acid-NHS Ester |
99 |
h |
2024-12-25 |
74573 |
mPEG5-OCH2CH2COOH;甲氧基五聚乙二醇丙酸 |
145 |
wyh |
2024-12-25 |
74574 |
5-[4-(3,5-二-十二烷氧基苯甲酰亚胺基)苯基]-10,15,20-三苯基卟啉配体(DDTPP) |
93 |
WYQ |
2024-12-25 |
74575 |
cas:55750-62-4,3-(Maleimido)propionic acid N-hydroxysuccinimide ester |
141 |
h |
2024-12-25 |
74576 |
Meso-四(4-十四氨基甲酰苯基)卟啉(14AFPP) |
107 |
WYQ |
2024-12-25 |
74577 |
mPEG12-OH , 甲氧基十二聚乙二醇-羟基 |
137 |
wyh |
2024-12-25 |
74578 |
cas:1305053-43-3,15-(2-pyridyldithio)-4,7,10,13-tetraoxapentadecanoic acid N-hydroxysuccinimide ester |
86 |
h |
2024-12-25 |
74579 |
4-甲酰苯甲酸N-琥珀酰亚胺酯,60444-78-2,ADC试剂 |
121 |
hyy |
2024-12-25 |
74580 |
Meso-5,10,15,20-四(对氯苯基)卟啉;TP-ClPPH2 |
116 |
WYQ |
2024-12-25 |
74581 |
cas:317331‐86‐5,N-succinimidyl-5-(2-pyridyldithio)valerate |
94 |
h |
2024-12-25 |
74582 |
cas:663599-11-9,1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
111 |
h |
2024-12-25 |
74583 |
mPEG7-NH2,甲氧基七聚乙二醇-氨基 |
125 |
wyh |
2024-12-25 |
74584 |
Zn-5,10,15,20-四(4-羧基苯基)卟啉(TCPP-Zn) |
134 |
WYQ |
2024-12-25 |
74585 |
N3-PEG4-C2-Pfp ester,1353012-00-6,抗体- 药物偶联物 |
84 |
hyy |
2024-12-25 |
74586 |
cas:341498-08-6,N-Succinimidyl 4-(2-pyridyldithio)pentanoate |
137 |
h |
2024-12-25 |
74587 |
mPEG16-NH2 ,cas:907577-50-8 ,甲氧基十六聚乙二醇-氨基 |
116 |
wyh |
2024-12-25 |
74588 |
cas:115088-06-7,N-Succinimidyl 4-(2-pyridyldithio)butanoate |
110 |
h |
2024-12-25 |
74589 |
mPEG48-Br,甲氧基四十八聚乙二醇溴代 |
91 |
wyh |
2024-12-25 |
74590 |
四价锰四苯基卟啉配合物,[XMnⅣ)TPP]2O(X=N3-或OCN-) |
130 |
WYQ |
2024-12-25 |
74591 |
mPEG11-Br,溴代十一甘醇单甲醚 |
82 |
wyh |
2024-12-25 |
74592 |
NHS-PEG4-azide,叠氮-PEG4-NHS酯,944251-24-5 ,ADC试剂 |
99 |
hyy |
2024-12-25 |
74593 |
cas:1610769-13-5,4-((S)-2-((S)-2-amino-3- methylbutanamido)-5- ureidopentanamido)benzyl 2-(pyridin- 2-yldisulfanyl)ethylcarbamate |
107 |
h |
2024-12-25 |
74594 |
mPEG4-OCH2COOH的结构特点,16024-66-1 |
114 |
wyh |
2024-12-25 |
74595 |
5,10,15,20-四-(对-十二酰氧基)苯基卟啉 (TLPPH2) |
88 |
WYQ |
2024-12-25 |
74596 |
四苯基钯卟啉(Pd TPP),卟啉类化合物 |
192 |
WYQ |
2024-12-25 |
74597 |
N3-PEG3-C2-NHS ester,1245718-89-1,抗体- 药物偶联物 |
89 |
hyy |
2024-12-25 |
74598 |
cas:2353409-52-4 Mal-amido-PEG8-val-gly-PAB-OH |
68 |
h |
2024-12-25 |
74599 |
mPEG24-NH-Mal ,甲氧基二十四聚乙二醇-NH-马来酰亚胺 |
84 |
wyh |
2024-12-25 |
74600 |
cas:330970-70-2 Alloc-Val-Ala-OH,抗体偶联药物 |
97 |
h |
2024-12-25 |
74601 |
mPEG3-SH ,甲氧基三聚乙二醇-巯基 |
105 |
wyh |
2024-12-25 |
74602 |
cas:150114-97-9 Fmoc-Val-Ala-OH,抗体偶联药物 |
113 |
h |
2024-12-25 |
74603 |
N3-PEG2-C2-NHS ester,1312309-64-0,ADC试剂 |
89 |
hyy |
2024-12-25 |
74604 |
Methyltetrazine-CH2NHCO-PEG12-CH2CH2NH2 |
82 |
zyl |
2024-12-25 |
74605 |
mPEG11-OH,甲氧基十一聚乙二醇-羟基 |
79 |
wyh |
2024-12-25 |
74606 |
cas:70396-18-8 Boc-Val-Ala-OH,抗体偶联药物 |
93 |
h |
2024-12-25 |
74607 |
cas:2348405-93-4 DBCO-PEG4-Val-Ala-PAB-PNP,抗体偶联药物 |
92 |
h |
2024-12-25 |
74608 |
mPEG5-OH , 甲氧基五聚乙二醇-羟基 |
83 |
wyh |
2024-12-25 |
74609 |
cas:2762519-08-2 endo-BCN-PEG4-Val-Cit-PAB-MMAE |
107 |
h |
2024-12-25 |
74610 |
Methyltetrazine-CH2NHCO-PEG7-CH2CH2NH2 |
80 |
zyl |
2024-12-25 |